Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 1.00 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | DDO | Q99489 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 3/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32895 | 1.00 | CA2 (1.00) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL28568569 | 0.83 | CA2 (0.71) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL329510 | 0.82 | CA2 (0.69) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL28535223 | 0.81 | CA2 (0.66) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL29560278 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL5610313 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL7014167 | 0.80 | CA2 (0.67) | CA2AOC3AKR1B1DAODDO | |
| SCHEMBL516901 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL517161 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL30437414 | 0.79 | CA2 (0.66) | CA2CA12CA1CA9AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704836-A1 | HETEROAROMATIC INDOLESULFONAMIDES | Seed Therapeutics, Inc (US) | 2026-03-11 | — | — | EP | disclosed |